Evidence map›Paper›PMID 35684514›Full record

ReviewMolecules (Basel, Switzerland)2022

Tianyu Hou, Vasudeva Reddy Netala, Hongjiao Zhang, Yun Xing, Huizhen Li, Zhijun Zhang

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. The Antiviral Potential ofMolecules (Basel, Switzerland) · 2024
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Chemo-enzymatic Approach to (Organic process research & development · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Plant-Based Care and Therapy in Ophthalmology.Antioxidants (Basel, Switzerland) · 2025
    Review
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tianyu HouSchool of Chemical Engineering and Technology, North University of China, Taiyuan 030051, China.ORCID 0000-0001-7939-7271
Vasudeva Reddy NetalaSchool of Chemical Engineering and Technology, North University of China, Taiyuan 030051, China.
Hongjiao ZhangSchool of Chemical Engineering and Technology, North University of China, Taiyuan 030051, China.ORCID 0000-0002-9228-587X
Yun XingGraduate School of Humanities, Nagoya University, Nagoya 4648601, Japan.
Huizhen LiSchool of Chemical Engineering and Technology, North University of China, Taiyuan 030051, China.
Zhijun ZhangSchool of Chemical Engineering and Technology, North University of China, Taiyuan 030051, China.

Funding

Shanxi Scholarship Council of China HGKY2019075
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Perilla frutescensAnthocyaninsHumansInflammationPlant LeavesXanthine OxidaseAnthocyaninsXanthine Oxidasebioactive compoundsPerilla frutescenspharmacological activitiessecondary metabolites

Identifiers

PMID35684514
PMCPMC9182122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.